A citation-based method for searching scientific literature

Jaclyn F Hechtman, Ryma Benayed, David M Hyman, Alexander Drilon, Ahmet Zehir, Denise Frosina, Maria E Arcila, Snjezana Dogan, David S Klimstra, Marc Ladanyi, Achim A Jungbluth. Am J Surg Pathol 2017
Times Cited: 190



Beth T Harrison, Elizabeth Fowler, Gregor Krings, Yunn-Yi Chen, Gregory R Bean, Anne Vincent-Salomon, Laetitia Fuhrmann, Sandra E Barnick, Beiyun Chen, Elizabeth M Hosfield, Jason L Hornick, Stuart J Schnitt. Am J Surg Pathol 2019
Times Cited: 16




List of shared articles



Times cited


Pan-TRK Immunohistochemistry: An Example-Based Practical Approach to Efficiently Identify Patients With NTRK Fusion Cancer.
Esther Conde, Susana Hernandez, Elena Sanchez, Rita Maria Regojo, Carmen Camacho, Marta Alonso, Rebeca Martinez, Fernando Lopez-Rios. Arch Pathol Lab Med 2021
2

Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Hidetaka Yamamoto, Yui Nozaki, Azusa Sugii, Kenichi Taguchi, Takahiro Hongo, Rina Jiromaru, Masanobu Sato, Takafumi Nakano, Kazuki Hashimoto, Minako Fujiwara,[...]. Hum Pathol 2021
0

Neurofibrosarcoma Revisited: An Institutional Case Series of Uterine Sarcomas Harboring Kinase-related Fusions With Report of a Novel FGFR1-TACC1 Fusion.
Kelly A Devereaux, Julianna J Weiel, Anne M Mills, Christian A Kunder, Teri A Longacre. Am J Surg Pathol 2021
2

Predictive 'biomarker piggybacking': an examination of reflexive pan-cancer screening with pan-TRK immunohistochemistry.
Lynette M Sholl, Mei Zheng, Valentina Nardi, Jason L Hornick. Histopathology 2021
1

[How to test for NTRK gene fusions: A practical approach for pathologists].
Arnaud Uguen, Marie Csanyi-Bastien, Jean-Christophe Sabourin, Frédérique Penault-Llorca, Julien Adam. Ann Pathol 2021
0


Molecular Testing in Breast Cancer: Current Status and Future Directions.
Lulu Sun, Ariel Wu, Gregory R Bean, Ian S Hagemann, Chieh-Yu Lin. J Mol Diagn 2021
0

Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.
L Cima, H Kaya, C Marchiò, R Nishimura, H Y Wen, V P Fabbri, M P Foschini. Virchows Arch 2021
0

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
Luiza N Weis, Sara M Tolaney, Carlos H Barrios, Romualdo Barroso-Sousa. NPJ Breast Cancer 2021
0

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
Alessandro Gambella, Rebecca Senetta, Giammarco Collemi, Stefano Gabriele Vallero, Matteo Monticelli, Fabio Cofano, Pietro Zeppa, Diego Garbossa, Alessia Pellerino, Roberta Rudà,[...]. Int J Mol Sci 2020
19

Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Eiichi Sasaki, Katsuhiro Masago, Shiro Fujita, Hidenori Suzuki, Nobuhiro Hanai, Waki Hosoda. Am J Surg Pathol 2020
14